A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Xenco Medical Expands its Ambulatory Surgery Center Device Portfolio with FDA Clearance and Launch of its Multilevel CerviKit

Xenco Medical has expanded its ASC surgical device portfolio through the FDA clearance and launch of its Multilevel CerviKitTM, an expansion of Xenco Medical’s breakthrough single-use cervical spine technology to include a comprehensive suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.

Optimized for the ambulatory surgery center setting, the Multilevel CerviKit builds on Xenco Medical’s existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit and adds to its portfolio of single-use lumbar surgical devices. The cervical plating options included in the Multilevel CerviKit feature an optimally thin profile, an intuitive locking mechanism, and a dual textured surface for thorough fixation.

The surgical platform is a sterile-packaged, single-use system designed to enhance intraoperative efficiency. Matched with a disposable delivery instrument and coupled with corresponding, single-use surgical instruments, the Multilevel CerviKit is engineered to complement Xenco Medical’s existing portfolio of single-use spinal systems.

Developed at the intersection of materials science and mechanical engineering, the highly reinforced, composite polymer instruments included with each of Xenco Medical’s multilevel anterior cervical plates allow for both consistent mechanical performance and the elimination of the costly logistics associated with the autoclave process. By expanding Xenco Medical’s current ASC portfolio, the Multilevel CerviKit is designed to strengthen an ambulatory surgery center’s ability to overcome sterilization bottlenecks while providing optimal care.

“As COVID-19 spurred increased demand for sterile-packaged, single-use spinal platforms and accelerated growth in the volume of outpatient cervical spine procedures, we have bolstered our commitment to expanding access to safer, streamlined surgical procedures through the launch of our single-use Multilevel CerviKit,” said Xenco Medical Founder and CEO Jason Haider.

Designed to be easily transportable, each Xenco Medical spinal system has been designed for both surgical performance and logistical efficiency. Unlike traditional instruments that are reused in hundreds of patients until a mechanical failure, the disposable Xenco Medical spinal implant systems are optimally calibrated and sterile-packaged for individual use. The product of advanced materials science, Xenco Medical’s single-use spinal implant systems are designed to be compatible with the company’s intelligent surgical vending machines and can be trained on using Xenco Medical’s glasses-free holographic surgical simulation platform.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy